These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 18160470)
1. Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes. Yamamoto M; Yamaguchi T; Yamauchi M; Yano S; Sugimoto T J Clin Endocrinol Metab; 2008 Mar; 93(3):1013-9. PubMed ID: 18160470 [TBL] [Abstract][Full Text] [Related]
2. Low serum level of the endogenous secretory receptor for advanced glycation end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes. Yamamoto M; Yamaguchi T; Yamauchi M; Sugimoto T Diabetes Care; 2009 Dec; 32(12):2263-8. PubMed ID: 19752174 [TBL] [Abstract][Full Text] [Related]
3. Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes. Ardawi MS; Akhbar DH; Alshaikh A; Ahmed MM; Qari MH; Rouzi AA; Ali AY; Abdulrafee AA; Saeda MY Bone; 2013 Oct; 56(2):355-62. PubMed ID: 23845326 [TBL] [Abstract][Full Text] [Related]
4. Serum insulin-like growth factor-I level is associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes mellitus. Kanazawa I; Yamaguchi T; Yamamoto M; Yamauchi M; Yano S; Sugimoto T Osteoporos Int; 2007 Dec; 18(12):1675-81. PubMed ID: 17632742 [TBL] [Abstract][Full Text] [Related]
5. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women. Yamaguchi T; Kanatani M; Yamauchi M; Kaji H; Sugishita T; Baylink DJ; Mohan S; Chihara K; Sugimoto T Calcif Tissue Int; 2006 Jan; 78(1):18-24. PubMed ID: 16397738 [TBL] [Abstract][Full Text] [Related]
6. Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus. Yamamoto M; Yamauchi M; Sugimoto T J Clin Endocrinol Metab; 2013 Oct; 98(10):4030-7. PubMed ID: 23894157 [TBL] [Abstract][Full Text] [Related]
7. Urinary Pentosidine levels negatively associates with trabecular bone scores in patients with type 2 diabetes mellitus. Choi YJ; Ock SY; Jin Y; Lee JS; Kim SH; Chung Y- Osteoporos Int; 2018 Apr; 29(4):907-915. PubMed ID: 29322222 [TBL] [Abstract][Full Text] [Related]
8. Relationships between dimethylarginine and the presence of vertebral fractures in type 2 diabetes mellitus. Kanazawa I; Yano S; Yamaguchi T; Notsu Y; Nabika T; Sugimoto T Clin Endocrinol (Oxf); 2010 Oct; 73(4):463-8. PubMed ID: 20550537 [TBL] [Abstract][Full Text] [Related]
9. Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes. Yamaguchi T; Kanazawa I; Yamamoto M; Kurioka S; Yamauchi M; Yano S; Sugimoto T Bone; 2009 Aug; 45(2):174-9. PubMed ID: 19446053 [TBL] [Abstract][Full Text] [Related]
10. Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications. Yamamoto M; Yamaguchi T; Yamauchi M; Kaji H; Sugimoto T J Bone Miner Res; 2009 Apr; 24(4):702-9. PubMed ID: 19049338 [TBL] [Abstract][Full Text] [Related]
11. Serum insulin-like growth factor-I is a marker for assessing the severity of vertebral fractures in postmenopausal women with type 2 diabetes mellitus. Kanazawa I; Yamaguchi T; Sugimoto T Osteoporos Int; 2011 Apr; 22(4):1191-8. PubMed ID: 20532480 [TBL] [Abstract][Full Text] [Related]
12. Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus. Tanaka KI; Kanazawa I; Kaji H; Sugimoto T Bone; 2017 Feb; 95():5-10. PubMed ID: 27836731 [TBL] [Abstract][Full Text] [Related]
13. Discordance between Prevalent Vertebral Fracture and Vertebral Strength Estimated by the Finite Element Method Based on Quantitative Computed Tomography in Patients with Type 2 Diabetes Mellitus. Kiyohara N; Yamamoto M; Sugimoto T PLoS One; 2015; 10(12):e0144496. PubMed ID: 26642210 [TBL] [Abstract][Full Text] [Related]
14. Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus. Kanazawa I; Yamaguchi T; Yamamoto M; Yamauchi M; Yano S; Sugimoto T Eur J Endocrinol; 2009 Feb; 160(2):265-73. PubMed ID: 18996964 [TBL] [Abstract][Full Text] [Related]
15. Incident Fracture Risk in Type 2 Diabetic Postmenopausal Women in Mainland China: Peking Vertebral Fracture Study. Jiajue R; Qi X; Jiang Y; Wang Q; Wang W; Pei Y; Wang X; Huang W; Zheng X; Ning Z; Wang O; Li M; Xing X; Yu W; Xu L; Xia W Calcif Tissue Int; 2019 Nov; 105(5):466-475. PubMed ID: 31511960 [TBL] [Abstract][Full Text] [Related]
16. Pentosidine and carboxymethyl-lysine associate differently with prevalent osteoporotic vertebral fracture and various bone markers. Nakano M; Nakamura Y; Suzuki T; Miyazaki A; Takahashi J; Saito M; Shiraki M Sci Rep; 2020 Dec; 10(1):22090. PubMed ID: 33328494 [TBL] [Abstract][Full Text] [Related]
17. The presence and severity of vertebral fractures is associated with the presence of esophageal hiatal hernia in postmenopausal women. Yamaguchi T; Sugimoto T; Yamada H; Kanzawa M; Yano S; Yamauchi M; Chihara K Osteoporos Int; 2002; 13(4):331-6. PubMed ID: 12030548 [TBL] [Abstract][Full Text] [Related]
18. Plasma level of homocysteine associated with severe vertebral fracture in postmenopausal women. Kuroda T; Tanaka S; Saito M; Shiraki Y; Shiraki M Calcif Tissue Int; 2013 Sep; 93(3):269-75. PubMed ID: 23793599 [TBL] [Abstract][Full Text] [Related]
19. Restrictive pulmonary dysfunction is associated with vertebral fractures and bone loss in elderly postmenopausal women. Watanabe R; Shiraki M; Saito M; Okazaki R; Inoue D Osteoporos Int; 2018 Mar; 29(3):625-633. PubMed ID: 29218382 [TBL] [Abstract][Full Text] [Related]
20. High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control. Neumann T; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Sämann A Osteoporos Int; 2014 May; 25(5):1527-33. PubMed ID: 24599273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]